- Package
- 10 g
- Purity
- 98%
- Price
- Request review
- Availability
- Shipping review required
- Delivery
- Shipping review required
CAS Number: 129618-40-2
Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.
Available options
Shipping review is required before pricing or stock can be confirmed publicly. Shipping, duties, and documentation fees are confirmed before order acceptance.
CAS Number
129618-40-2
PubChem CID
4463
Molecular Formula
C15H14N4O
Molecular Weight
266.3 g/mol
Exact Mass
266.116761
InChIKey
NQDJXKOVJZTUJA-UHFFFAOYSA-N
IUPAC Name
2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
SMILES String
CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4
Melting Point
196.1 °C
pKa
2.8
Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.
Structural features
Nevirapine (CAS 129618-40-2) is listed in the Pharmaceutical Intermediates portfolio, with molecular formula C15H14N4O and molecular weight 266. 30 g/mol.
Sourcing context
Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.
Research use context
Intended for research-stage medicinal chemistry and intermediate synthesis workflows; structure-derived tags include nitrogen-containing heterocycle.
Documentation needs
COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.
ChEMBL reports experimental activity evidence for: Human immunodeficiency virus type 1 reverse transcriptase (Human immunodeficiency virus 1) — 396 assays; Human immunodeficiency virus type 1 protease (Human immunodeficiency virus 1) — 3 assays; Alpha-1A adrenergic receptor (Homo sapiens) — 4 assays; Cannabinoid receptor 1 (Homo sapiens) — 4 assays; 5-hydroxytryptamine receptor 1A (Homo sapiens) — 3 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.
Human immunodeficiency virus type 1 reverse transcriptase
Human immunodeficiency virus 1 · SINGLE PROTEIN · 396 qualifying assays · 198 documents · best pChEMBL 8.44
Experimental evidence source: ChEMBL
Human immunodeficiency virus type 1 protease
Human immunodeficiency virus 1 · SINGLE PROTEIN · 3 qualifying assays · 1 documents · best pChEMBL 7
Experimental evidence source: ChEMBL
Alpha-1A adrenergic receptor
Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
Cannabinoid receptor 1
Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
5-hydroxytryptamine receptor 1A
Homo sapiens · SINGLE PROTEIN · 3 qualifying assays · 1 documents
Experimental evidence source: ChEMBL
For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.
Preliminary Safety Reference
For supplier-issued SDS or COA, submit a documentation request.
Safety Reference / SDS RequestCatalog navigation
Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.
Nevirapine is identified by CAS 129618-40-2, with molecular formula C15H14N4O, molecular weight 266.3, InChIKey NQDJXKOVJZTUJA-UHFFFAOYSA-N.
ChEMBL contains qualifying experimental assay evidence associated with Human immunodeficiency virus type 1 reverse transcriptase, Human immunodeficiency virus type 1 protease, Alpha-1A adrenergic receptor, Cannabinoid receptor 1, 5-hydroxytryptamine receptor 1A. These records do not establish therapeutic efficacy or clinical use.
Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.
Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.
Availability, pack size, lead time, and pricing are confirmed through RFQ.
Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.